These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3895661)

  • 1. Nephrotoxicity of cyclosporine in liver transplantation.
    Iwatsuki S; Esquivel CO; Klintmalm GB; Gordon RD; Shaw BW; Starzl TE
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):191-5. PubMed ID: 3895661
    [No Abstract]   [Full Text] [Related]  

  • 2. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive?
    Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657
    [No Abstract]   [Full Text] [Related]  

  • 3. Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone.
    Simmons RL; Canafax DM; Strand M; Ascher NL; Payne WD; Sutherland DE; Najarian JS
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):266-75. PubMed ID: 3895665
    [No Abstract]   [Full Text] [Related]  

  • 4. Overcoming early cyclosporine nephrotoxicity after liver transplantation.
    Burdick JF; Colombani PM; Pitt HA; Perler BA; Merritt WT; Crandall BC; Mitchell MC; Herlong HF; Williams GM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2236-7. PubMed ID: 2652724
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects on renal function of combined treatment with trimethoprim and cyclosporine A in kidney transplant patients.
    Berg KJ; Nordby G; Rootwelt K; Djøseland O; Fauchald P; Mehl A; Narverud J; Talseth T
    Transplant Proc; 1988 Jun; 20(3):413-5. PubMed ID: 3289171
    [No Abstract]   [Full Text] [Related]  

  • 6. Is cyclosporine-associated nephrotoxicity progressive?
    Vanrenterghem Y; Waer M; Roels L; Lerut T; Michielsen P
    Transplant Proc; 1987 Oct; 19(5):4031-2. PubMed ID: 3313992
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclosporine nephrotoxicity in orthotopic liver transplantation.
    Gonwa TA; Poplawski SC; Husberg BS; Nery JR; Klintmalm GB
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):401-4. PubMed ID: 3291276
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjunctive azathioprine and antilymphocyte serum immunosuppression with cyclosporine.
    Ford HR; Fryd DS; Canafax DM; Ascher NL; Dunn D; Sutherland DE; Najarian JS; Simmons RL
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):8-12. PubMed ID: 3291316
    [No Abstract]   [Full Text] [Related]  

  • 10. Nephrotoxicity in patients with rheumatoid arthritis treated with cyclosporine.
    Ludwin D; Bennett KJ; Grace EM; Buchanan WW; Bensen W; Bombardier C; Tugwell PX
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):367-70. PubMed ID: 3381299
    [No Abstract]   [Full Text] [Related]  

  • 11. Functional consequences and risk factors of chronic cyclosporine nephrotoxicity in type I diabetes trials.
    Feutren G
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):356-66. PubMed ID: 3381298
    [No Abstract]   [Full Text] [Related]  

  • 12. Monitoring of cyclosporine by serial posttransplant pharmacokinetic studies in renal transplant patients.
    Awni WM; Heim-Duthoy K; Kasiske BL
    Transplant Proc; 1990 Jun; 22(3):1343-4. PubMed ID: 2349693
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclosporine nephrotoxicity: exploration of the risk factors and prognosis of the renal injury.
    Keown PA; Stiller CR; Wallace AC; McKenzie FN; Wall W
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):247-53. PubMed ID: 3895663
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal function following liver transplantation in children.
    Sommerauer JF; Howard J; Grant D
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1466-8. PubMed ID: 1989267
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of nephrotoxic cyclosporine peak concentrations by daily drug division in 3 equal oral portions.
    Zazgornik J; Schindler J; Balcke P; Kopsa H; Gremmel F; Derfler K; Kretschmer G; Mühlbacher F; Piza F
    Int J Clin Pharmacol Ther Toxicol; 1987 Apr; 25(4):197-200. PubMed ID: 3294613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The case against conversion to azathioprine in cyclosporine-treated renal recipients.
    Flechner SM; Lorber M; Van Buren C; Kerman R; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):276-81. PubMed ID: 3895667
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclosporine A nephrotoxicity in liver graft recipients: determination of nephrotoxic cyclosporine blood concentrations in liver graft recipients as defined by the HPLC and RIA tests.
    Hamilton G; Mühlbacher F; Roth E; Steininger R; Wolf I; Schindler J; Wolosczuk W; Piza F
    Transplant Proc; 1987 Oct; 19(5):4045-8. PubMed ID: 3313996
    [No Abstract]   [Full Text] [Related]  

  • 18. The case against the indefinite use of cyclosporine.
    Myers BD; Newton L; Oyer P
    Transplant Proc; 1991 Feb; 23(1 Pt 1):41-2. PubMed ID: 1990570
    [No Abstract]   [Full Text] [Related]  

  • 19. The spectrum of ciclosporin nephrotoxicity.
    Puschett JB; Greenberg A; Holley J; McCauley J
    Am J Nephrol; 1990; 10(4):296-309. PubMed ID: 2240057
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of cyclosporine A on long-term renal function in pediatric liver transplant recipients.
    Andrews WA; Arant BS; Fyock B; Gray S; Schlatter MG; Conlin C
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1452-3. PubMed ID: 1989261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.